Related Experiment Video
Updated: Dec 14, 2025

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
CLEC3B protects H9c2 cardiomyocytes from apoptosis caused by hypoxia via the PI3K/Akt pathway
Fenghua Lv1, Zhuo Wang1, Yanli Huang1
1Department of Cardiology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China.
Insights
C-type lectin domain family 3 member B (CLEC3B) protects against ischemic heart disease (IHD) injury by activating the PI3K/Akt pathway. This study reveals CLEC3B
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Cellular Physiology
Background:
- Ischemic heart disease (IHD) is a major global health concern.
- C-type lectin domain family 3 member B (CLEC3B) is implicated in tissue remodeling, with lower serum levels in cardiovascular disease patients.
- The precise role and molecular mechanisms of CLEC3B in IHD remain unclear.
Purpose of the Study:
- To investigate the protective role and molecular mechanisms of CLEC3B in an in vitro model of IHD.
- To elucidate the involvement of the PI3K/Akt signaling pathway in CLEC3B-mediated protection.
Main Methods:
- Overexpression and silencing of CLEC3B in H9c2 rat cardiomyocytes.
- Establishment of an in vitro IHD model using hypoxic conditions.
- Assessment of cell viability, apoptosis, and protein expression via CCK-8, flow cytometry, qRT-PCR, and Western blot.
Main Results:
- CLEC3B expression was reduced under hypoxic conditions.
- CLEC3B overexpression enhanced cell viability, reduced apoptosis, and upregulated p-PI3K/PI3K and p-Akt/Akt levels.
- CLEC3B overexpression downregulated cleaved-caspase 3 expression, while CLEC3B silencing had opposite effects.
- Inhibition of the PI3K/Akt pathway abrogated the protective effects of CLEC3B.
Conclusions:
- CLEC3B exerts a protective effect against hypoxic injury in cardiomyocytes.
- CLEC3B alleviates IHD-induced cardiomyocyte injury by activating the PI3K/Akt signaling pathway.
- CLEC3B represents a potential therapeutic target for managing ischemic heart disease.
Abstract:
Ischemic heart disease (IHD) is one of the leading causes of death worldwide. C-type lectin domain family 3 member B (CLEC3B) is a C-type lectin superfamily member and is reported to promote tissue remodeling. The serum levels of CLEC3B are downregulated in patients with cardiovascular disease. However, the molecular mechanisms of CLEC3B in IHD is not well-characterized. Therefore, we overexpressed CLEC3B and silenced CLEC3B in H9c2 rat cardiomyocytes for the first time. We then constructed a model of IHD in vitro through culturing H9c2 cardiomyocytes in serum-free medium under oxygen-deficit conditions. Then, Cell Counting Kit-8 (CCK-8), flow cytometry, qRT-PCR, and western blot assays were performed to investigate cell viability, apoptosis, and expression levels of CLEC3B, phosphatidylinositol 3-kinase (PI3K), phosphorylated PI3K (p-PI3K), protein kinase B (Akt), phosphorylated Akt (p-Akt), and cleaved-caspase 3. We observed that the mRNA expression of CLEC3B was decreased in hypoxic H9c2 cardiomyocytes (P<0.05). Overexpression of CLEC3B increased cell viability (P<0.01), inhibited cell apoptosis (P<0.05), upregulated the levels of p-PI3K/PI3K and p-Akt/Akt (P<0.01 or P<0.05), and downregulated expression of cleaved-caspase 3 (P<0.001) in hypoxic H9c2 cardiomyocytes while silencing of CLEC3B caused the opposite results. Inhibition of the PI3K/Akt pathway reversed the protective effect of CLEC3B on hypoxic H9c2 cardiomyocytes. Our study demonstrated that CLEC3B alleviated the injury of hypoxic H9c2 cardiomyocytes via the PI3K/Akt pathway.
Related Concept Videos
Caspases
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Cell Specific Gene Expression
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Apoptosis

